Serum lipid profiles in acute myocardial infarction patients in Gorgan

Biomedical Research

Volumn 23, Issue 1, 2012, Pages 119-124

  Shirafkan, Ahmad ^a   Marjani, Abdoljalal ^a   Zaker, Farhad ^b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute myocardial infarction; Gorgan; Lipid profiles

Indexed keywords

CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; TRIACYLGLYCEROL; UREA; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; EATING HABIT; FEMALE; HUMAN; IRAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; SOCIAL BEHAVIOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84859826587     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Camm AJ. Cardiovascular disease. In: Kumar P, Clark M. Clinical Medicine. 5th ed. London: Bath Press, 2002: 766-783.
2. Ahmed IA. Myocardial-infraction based on intelligent techniques. Am J Applied Sci 2010; 7: 349-351.
3. Dehlaghi V, Najarian S, Shadpour MT. Effect of stent geometry on phase shift between pressure and flow waveforms in stented human coronary artery. Am J Applied Sci 2008; 5: 340-346.
4. Jahromi AS, Shojaie M, Dana S, Madani A. Anticardiolipin antibody in acute myocardial infarction. Am J Immunol 2010; 6: 11-14.
5. Zimmerman FH, A. Cameron LD, Ng G. Myocardial infarction in young adults: Angiographic characterization, risk factors and prognosis (coronary artery surgery study registry). J Am Coll Cardiol 1995; 26: 654-661.
6. Braunwald E. Approach to the patient with cardiovascular disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's Principles of Internal Medicine; 16th ed. New York: McGraw-Hill, 2005; 1301-1494.
7. World Health Organization. The World Health Report: reducing risks, promoting healthy life [Online]. 2002; Available from: URL: http://www.who.int/whr/2002/-en.
8. Sarrafzadegan N, Boshtam M, Malekafzali H, Bashardoost N, Sayedtabatabaei FA, Rafiei M, et al. Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. Acta Cardiol 1999; 54 (6): 327-333.
9. Azizi F, Hatami H, Janghorbani M. Epidemiology of Common Diseases in Iran. 2nd ed. Tehran Didavar Company, 2001; pp. 10-22.
10. Biorch, G., Blomquist, G. and Sievers, J. Cholesterol values in patients with myocardial infarction and normal control group. Acta Med Scand 1957; 156: 493-497.
11. Bjorntrop P, Malmcrone R. Serum cholesterol in patient with myocardial infarction in younger ages. Acta Med Scand 1960; 168: 151-155.
12. Dodds, C. and Mills, G.L. Influence of myocardial infarction on plasma lipoprotein concentration. Lancet. 1959; 1160-1163.
13. Tibblin G, Cramer K. Serum lipids during the course of acute myocardial infarction and one year afterwards Acta Med Scand 1963; 174, 451-455.
14. Fyfe T, Baxter RH, Cochran KM, Booth EM. Plasma lipid changes'after myocardial infarction. Lancet. 1971; 997-1001.
15. Kirkeby K. Disturbances in serum lipids and in their fatty' acid composition following acute myocardial infarction. Acta Med Scand 1972; 192: 523-528.
16. Avogaro A, Bittilin Bon G, Cazzalato C, Quinci GB, Sanson A, Sparla H, Zagatti GC. Variations in apolipoproteins B and A during the course of myocardial infarction. Eur. J. Clin. Invest. 1978; 8; 121-129.
17. Ballantyne FC, Melville DA, McKenna JP, Morrison BA, Ballantyne D. Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin Chim Acta 1979; 99: 85-92.
18. Ryder REJ, Hayes TM, Mulligan IP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J 1984; 289: 1651-1653.
19. Jackson, R., Scragg, R., Marshall, R, White, O'Brien, K. and Small, C. Changes is serum lipid concentrations during first 24, hours after myocardial infarction. Br. Med. J. 1987; 294, 1588-1589.
20. Heldenburg, D., Rubenstein, A., Levtov, O., Berns, L., Werbin, B. and Tamir, L. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis. 1980; 35, 433-437.
21. Fredrickson, D.S. The role of lipids in acute myocardial infarction. Circulation. 1969; 39, Suppl. IV-99-IV-III.
22. Swedarsen, M., Vythilingum, S., Jialal, I. and Nadar, R. Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. Postgrad. Med. J. 1988; 64, 352-356.
23. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 27: 4-12.
24. Linn S, Fulwood R, Carroll M, et al. Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health 1991; 81: 1038-1043.
25. Jialal I, Devaraj S. Low density lipoprotein oxidation, antioxidants and atherosclerosis. Clin Chem. 1996; 42: 498-506.
26. Bitla AR, Pallavi M, Vanaja V, Suchitra MM, Reddy Seshadri V, Prabhakar Reddy E, Srinivasa Rao P.V.L.N. Acute Myocardial Infarction in a Southeast Indian Population: Comparison of Traditional and Novel Cardiovascular Risk Factors Research Journal of Medicine and Medical Sciences. 2009; 4(2): 202-206.
27. Ryder REJ, Hayes TM, Mulligan IP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J 1984; 289; 1651-1653.
28. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1974; 284-289.
29. Berlin R, Oldfelt CO, Vikrot O. Acute myocardial infraction and plasma phospholipids levels. Acta Med. Scand. 1969; 185, 439-442.
30. Pocock SJ, Shaper AG, Philips AN, Walker M, Whitehead TP. High density lipoprotein cholesterol is not a major risk factor for ischemic heart disease. British Medical Journal. 1986; 292: 515-519.
31. Salahuddin, Karira KA, Shah SMA, et al. Serum homocysteine in patients with acute myocardial infarction. Pakistan J Cardiol. 2000; 11: 93-99.
32. Goldstein JL, Hazzard WR, Schrott HG: Hyperlipidemia in coronary heart disease. J Clin Invest. 1973; 52: 1533-1543.
33. Watts GF, Jackson P, Mandalia S. Nutrient intake and progression of coronary artery disease. Am J Cardiol. 1994; 73: 328-332.
34. Fredrickson DS. The role of lipids in acute myocardial infarction. Circulation. 1969; 39, Suppl. IV-99-IV-III
35. Dyerberg J, Bang, H.O. and Neilsen, J.A. Plasma lipids and lipoproteins in patients with myocardial infarction and in a control material. Acta Med. Scand. 1970; 187, 353-359.
36. Bjorntrop P, Malmcrone R. Serum cholesterol in patient with myocardial infarction in younger ages. Acta. Med. Scand. 1960; 168, 151-155.
37. Tibblin G, Cramer K. Serum lipids during the course of acute myocardial infarction and one year afterwards Acta Med. Scand. 1963; 174, 451-455.
38. Kirkeby K. Disturbances in serum lipids and in their fatty' acid composition following acute myocardial infarction. Acta Med Scand 1972;192, 523-528.
39. Jackson R, Scragg R, Marshall R, White O'Brien K, Small C. Changes in serum lipid concentrations during first 24, hours after myocardial infarction. Br. Med. J. 1987; 294, 1588-1589.
40. Heldenburg D, Rubenstein A, Levtov O, Berns L, Werbin B, Tamir L. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis.1980; 35: 433-437.
41. Garcia RM, Sorlie P, Costas R. Relationship of dietary intake to subsequent coronary heart disease incidence. American Journal of Clinical Nutrition 1980; 33:1818.
42. Hargreaves AD, Logan RL and Thomson M: Total cholesterol, LDL-Ch and HDL-Ch and coronary heart disease BMJ 1991; 303:678.
43. Natio HK. The association of serumlipids, lipoproteins and apolipoproteins with coronary artery disease assessed by coronary arteriography. Ann. N.Y. Acad. Sci. 1985; 454, 230-238.
44. Zampogna A, Luria MH, Mancibens SJ, Luria MA. Relationship between lipids and occlusive coronary disease. Arch. Intern Med 1980; 140, 1067-1069.
45. Luria MH, Erel J, Sapoznikov D, Gotsman MS. Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. Am. J. Cardiol. 1991; 67, 31-36.
46. Ballantyne FC, Melville DA, McKenna JP, Morrison BA, Ballantyne D. Response of plasma lipoproteins and acute phase proteins to myocardial infarction. Clin. Chim Acta 1979; 99, 85-92.
47. Sandkamp M, Funke H and Schulte H: Lipoprotein (a) is an independent risk factor for myocardial infarction. Clin Chem 1990; 36: 20-23.
48. Grundy SM, Vega GL, Kesaniemi YA. Abnormalities in metabolism of LDL associated with coronary heart disease. Acta Medica Scand 1985; 701: 23-37.
49. Ball M and Mann JJ: Apoproteins: predictors of coronary heart disease? Br Med J 1986; 27: 769-770.
50. Kromhout D: Body weight, diet and serum cholesterol in middle aged men during 10 years follow up. Am J Clin Nutr. 1983; 38: 591-598.